TEL AVIV, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative ...
TEL AVIV - Nasus Pharma Ltd. (NYSE:NSRX) has entered into a securities purchase agreement with institutional and accredited investors for a private placement expected to raise approximately $15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results